Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
Lilly posts Phase 3 orforglipron results; registers new MDD trial and five other updatesOct 2Weekly roundup, 10 itemsbaricitinibbrenipatideUpdated
Lilly raises 2026 revenue guidance to $85-87 billion on Mounjaro, Zepbound growthAug 5Quarterly updateEli Lillytirzepatide